Trials / Completed
CompletedNCT02171962
Zilver® PTX® in China
Evaluation of the Zilver® PTX® Drug-Eluting Peripheral Stent for Treatment of Lesions of the Above-the-Knee Femoropopliteal Artery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 178 (actual)
- Sponsor
- Cook Group Incorporated · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the Zilver® PTX® Drug-Eluting Peripheral Stent for treatment of lesions of the above-the-knee femoropopliteal artery in a Chinese patient population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Zilver® PTX® Drug-Eluting Peripheral Stent | Zilver® PTX® Drug-Eluting Peripheral Stent for treatment of lesions of the above-the-knee femoropopliteal artery |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2015-12-01
- Completion
- 2017-02-09
- First posted
- 2014-06-24
- Last updated
- 2017-03-22
Locations
9 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02171962. Inclusion in this directory is not an endorsement.